Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-21-007765

Options or other derivatives

  • Chief Executive Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
FRIEDMAN PAUL A Chief Executive Officer 2021-02-22 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D
Loading xslF345X03/doc4.xml…